FDA
-
-
-
-
-
-
-
FDA clears Bayer's Kerendia for kidney disease in type 1 diabetes
-
-
-
-
-
-
-
Luke Bryan and One A Day® Launch Limited Edition Multivitamin Bottles Available Only at Walmart
-
-
-
-
-
-
-
ASCO 2026: Bayer to Present New Data Across Oncology Portfolio
-
-
-
-
-
-
-
Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis
-
-
-
-
-
-
-
Bayer's asundexian reduces stroke risk by 26% in phase III trial
-
-
-
-
-
-
-
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia
-
-
-
-
-
-
-
Bayer’s Lynkuet® (elinzanetant), the First and Only Neurokinin 1 and Neurokinin 3 Receptor Antagonist, Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause
-
333,471 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


